tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Dividend Date & History

Compare
1,411 Followers
Ocular Therapeutix (OCUL) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
MO
Altria Group
$3.998 (7.5%)
$92.08B
8.31
32.84%
3 Buy
3 Hold
1 Sell
Moderate Buy
T
AT&T
$1.108 (4.24%)
$187.71B
17.53
60.46%
20 Buy
4 Hold
0 Sell
Strong Buy
XRX
Xerox
$1 (12.45%)
$976.34M
-0.73
-58.07%
0 Buy
1 Hold
1 Sell
Moderate Sell
IBM
International Business Machines
$6.676 (2.52%)
$244.79B
41.17
43.72%
7 Buy
6 Hold
1 Sell
Moderate Buy
CVX
Chevron
$6.6 (4.11%)
$285.36B
16.34
0.96%
13 Buy
3 Hold
0 Sell
Strong Buy
EOG
EOG Resources
$3.705 (2.73%)
$76.31B
10.92
14.33%
10 Buy
8 Hold
0 Sell
Moderate Buy
ET
Energy Transfer
$1.282 (6.34%)
$68.42B
15.58
34.82%
8 Buy
1 Hold
0 Sell
Strong Buy
HESM
Hess Midstream Partners
$2.703 (6.39%)
$9.34B
16.57
16.95%
2 Buy
1 Hold
0 Sell
Moderate Buy
ARCC
Ares Capital
$1.916 (8.18%)
$15.71B
9.59
15.76%
7 Buy
1 Hold
0 Sell
Strong Buy

FAQ

Does Ocular Therapeutix pay dividends?
No, Ocular Therapeutix (OCUL) has not paid a dividend within the past 12 months.
    How much is Ocular Therapeutix's dividend?
    Ocular Therapeutix (OCUL) does not pay a dividend
    When is Ocular Therapeutix ex-dividend date?
    Ocular Therapeutix (OCUL) does not pay a dividend.
    When is Ocular Therapeutix dividend payment date?
    Ocular Therapeutix (OCUL) does not pay a dividend.
    Does Ocular Therapeutix have sufficient earnings to cover their dividend?
    The Ocular Therapeutix has paid a dividend in the last year and may provide dividends in the near future.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis